SlideShare uma empresa Scribd logo
1 de 32
Baixar para ler offline
Sample & Assay Technologies

GeneRead DNAseq Targeted Exon Enrichment &
GeneRead Library Quantification System for
Next Generation Sequencing
Shankar Sellappan, Ph.D.
Global Product Manager
Shankar.Sellappan@QIAGEN.com
1
Sample & Assay Technologies

Pathway-Focused Analysis Tools

2
Sample & Assay Technologies

GeneRead DNAseq & Library Quant NGS System

Agenda
 Introduction
 Targeted Enrichment
 Workflow
 Principles
 Data Analysis
 Pathway Content
 Performance Data
 Application Example
 Library Quantification
 Workflow
 Application Example
 Summary
3
Sample & Assay Technologies

Individual
participants

Cell cycle

P53
MDM2
Cyclins
CDKs

Biological Markers Define Biological Processes

Angiogenesis

VEGF
bFGF
ANGPT
PDGF

Inflammation

IL8
TLR
IFNγ
TNFβ

4
Sample & Assay Technologies

Complete Biological Story
Built on Pathway / Network Analysis

Angiogenesis

Inflammation

Pathway

Cell cycle

5
Sample & Assay Technologies

Patient sample =
Wild-type =

Determining DNA Differences

ATGCCATCTGGGACGGGTCAGTAG
ATGCCATCTGTGACGGGTCAGTAG

How could that SINGLE base difference make the person sick?
Let’s look at the amino acids that are translated in both samples:
Patient sample DNA =
Amino Acid Sequence =

ATG CCA TCT GGG ACG GGT CAG TAG
Met P S G T G Q Stop

Valine

Glycine

Compare the two amino acid sequences:
Patient sample AA Sequence =
Wild-Type AA Sequence =

Met P S G T G Q Stop
Met P S V T G Q Stop

If the wild-type protein, with the Valine positioned here, looked like:
and in the patient sample, it is a Glycine, and it looks like:
Well….the protein just won’t work.
6
Sample & Assay Technologies

What is NGS (Next Generation Sequencing)?
Massively Paralleled Sequencing

Instead of sequencing a DNA sequence from

Sequence many small pieces at the same time

7
Sample & Assay Technologies

When doing NGS analysis, what are you looking for?
Easy-to-use workflow and Data output

Detection of Low Prevalence Somatic Mutation in FFPE Lung Adenocarcinoma Sample

Human Lung Cancer GeneRead DNASeq Gene panel was used to enrich 20 genes in genomic DNA isolated from three
FFPE lung adenocarcinoma and one FFPE normal lung samples. Sequencing data was analyzed using QIAGEN NGS
Data Analysis Web Portal and high quality variants were filtered.

8
Sample & Assay Technologies

Your NGS research needs

 Identify low frequency DNA mutation variants
 Work with low quality DNA samples, such as FFPE
samples
 Focus efforts on a focused set of genes important to
their research
 Simple methodology to make variant calls
 Selective sequencing saves sequencing capacity

9
Sample & Assay Technologies

Traditional NGS Workflow

Isolate DNA

Library Prep & Quantification

NGS

Sequence Analysis &
Variant ID

• Whole genome analysis
• Too much irrelevant data
• Poor quality reads / coverage
10
Sample & Assay Technologies

New NGS Workflow with Targeted Enrichment
80 ng

Achieve more sensitive mutation detection
with 1 additional step

• Focused on your genes of interest
• Why look at all 20,000
genes in the human
genome when you are
interested in only a few?
• Enables deep sequencing to ID
low frequency mutation / rare
variants
• Integrated controls to assess
target enrichment

11
Sample & Assay Technologies

Target Enrichment: Principles
Multiplex PCR-enabled enrichment of gene of interest

We provide primer sets that produce overlapping PCR products
• For any gene or set of genes in the human genome

Division of non-adjacent gene primer sets into
4 tubes increases amplification specificity.
12
Sample & Assay Technologies

Targeted Enrichment: Details

~ 150 bp PCR
products

13
Sample & Assay Technologies

Complete Analysis Workflow
With integrated controls to assess sample quality / TE process

14
Sample & Assay Technologies

NGS Sequence Analysis and Variant ID Software

 FREE Complete & Easy to use Data Analysis with Web-based Software

15
Sample & Assay Technologies

Read Mode: Paired End vs Single End
Goal: Increased # of Reads / Amplicon

Sequence of Interest:
TACGCATCGATGCGGTAACTGCTGATCGTCGTAGTGCTAGCTGA

Single End Sequencing:
TACGCATCGATGCGGTAACTGCTGATCGTCGTAGTGCTAGCTGA
Paired End Sequencing (both ends are sequenced):
TACGCATCGATGCGGTAACTGCTGATCGTCGTAGTGCTAGCTGA

AGTCGATCGTGATGCTGCTAGTCGTCAATGGCGTAGCTACGCAT
Sample & Assay Technologies

How Genes on Panels Are Selected


Comprehensive Cancer Panel (124 genes)



Disease Focused Gene Panels (20 genes)


Breast cancer

Liver cancer



Colon Cancer

Lung Cancer



Gastric cancer

Ovarian Cancer



Leukemia

Prostate Cancer



Genes with High Relevance



Biologically relevant gene content
 Clinically relevant: Published association with the
disease state
– Multiple Publically accessible databases
– Text mining tools
– Manually curated



Genes Involved in Disease

ALSO AVAILABLE: Custom Panels from ANY GENE
or COLLECTION OF GENES in Human Genome

Technically relevant gene content
 Most frequently mutated genes
 Specific feedback from the thought leaders
17
Sample & Assay Technologies

Targeted Enrichment: Panel Information
Sample & Assay Technologies

Targeted Enrichment: Panel Information
Sample & Assay Technologies

NGS Target Enrichment Design Strategy
Commonly encountered issues solved by GeneRead Algorithm

•

Design Coverage
• How much of the gene is covered by your amplicons

•

Sequence Coverage Uniformity
• How much ease base pair is covered: Ideally, it should be uniform

•

Specificity
• % of reads mapped back to your sequence of interest

20
Sample & Assay Technologies

GeneRead DNAseq Gene Panel: Performance data

% Covered by Design

Design coverage

GeneRead DNAseq
Custom Panel

GeneRead DNAseq
Lung Cancer Panel

GeneRead DNAseq
Comprehensive Cancer Panel

Discover more potential variants by covering more exons
for genes of interest in assay design
21
Sample & Assay Technologies

GeneRead DNAseq Gene Panel: Performance data
Sequence coverage uniformity

GeneRead DNAseq
Custom Panel

GeneRead DNAseq
Lung Cancer Panel

GeneRead DNAseq
Comprehensive Cancer Panel

More bases sequenced above minimum read depth,
generating more high-quality consensus calls.
22
Sample & Assay Technologies

GeneRead DNAseq Gene Panel: Performance data

Specificity
(% on-target reads)

Specificity (On-target reads)*

GeneRead DNAseq
Custom Panel

GeneRead DNAseq
Lung Cancer Panel

GeneRead DNAseq
Comprehensive Cancer Panel

No wasting of sequencing capacity
* On-Target Reads= Number of reads on target out of total number of reads per run
23
Sample & Assay Technologies

DNAseq Gene Panel Application Data
KRAS:G12V is present in all three FFPE lung adenocarcinomas

Detection of Low Prevalence Somatic Mutation in FFPE Lung Adenocarcinoma Sample

Human Lung Cancer GeneRead DNASeq Gene panel was used to enrich 20 genes in genomic DNA isolated from three
FFPE lung adenocarcinoma and one FFPE normal lung samples. Sequencing data was analyzed using QIAGEN NGS
Data Analysis Web Portal and high quality variants were filtered.
NOTE: KRAS mutations confirmed by either Pyro or ARMS mutation assays (qBiomarker Somatic Mutation PCR Array)
24
Sample & Assay Technologies

Next-generation sequencing workflow
Where does Library Quantification fit within the NGS workflow?

Purification
and
amplification

Sample
enrichment

Library
preparation

Next generation
sequencing run

Result
verification

(Optional)

GeneRead (DNAseq) Library
Quantification and QC System

Why do you want to:
1. quantify their NGS DNA libraries
2. know the quality of their NGS DNA libraries?
 You have to, in order to ensure high quality reads
 Sequencing runs are expensive and time consuming, therefore, you want to ensure that
downstream sequencing analyses are performed on samples of adequate quality for
NGS technology.

25
Sample & Assay Technologies

Your needs

Potential problems in NGS if library not quantified
NGS methodology needs
 Too much DNA
 Mixed signals and un-resolvable data
 Too little DNA
 Reduced sequencing coverage
 Reduced read depth
 Empty runs
 Increase cost per run
 Wasted time
Your needs
 Simple and easy to perform method, with convenient and highthroughput format
 Fast
 Reliable and accurate quantification of sequencing targets
 Unmet need: Assess quality of target enriched DNA
 Efficient use of NGS capacity
Potential methods for library QC
 qPCR
 Bioanalyzer
 Qubit
26
Sample & Assay Technologies

Why choose qPCR for NGS Library Quantification?

1. BioAnalyzer measures total nucleic acids
- Why is this a problem?

2. Low limit of detection

3. Consistency of results
-

For each technology, the greater the
concentration of each sample (X-axis),
the greater the # of clusters
-

This should be a linear relationship

-

Only qPCR provides this
27
Sample & Assay Technologies

NGS Library Quantification Made Easy
Adapters can be quantified with qRT-PCR

Step 1: You have your DNA (whole genome or target enriched)

Step 2: You prepare the DNA library for NGS by adding (via ligation) NGS platformspecific adapters
 NOTE: The adapters are short pieces of DNA

Step 3: We provide you 2 reagents:
1. Pre-aliquoted dilutions of the standard
2. qPCR Primer Assays that detect the adapters

Step 4: You perform qPCR with your sample. It should fall between our standard curve
created with 5 sequential 10-fold dilutions. THAT is your library concentration to use in
preparing your NGS analysis.

28
Sample & Assay Technologies

NGS Library Quantification Made Easy
Adapters can be quantified with qRT-PCR

Step 1: You have your DNA (whole genome or target enriched)

Step 2: You prepare the DNA library for NGS by adding (via ligation) NGS platformspecific adapters
 NOTE: The adapters are short pieces of DNA

Step 3: We provide you 2 reagents:
1. Pre-aliquoted dilutions of the standard
2. qPCR Primer Assays that detect the adapters

Step 4: You perform qPCR with your sample. It should fall between our standard curve
created with 5 sequential 10-fold dilutions. THAT is your library concentration to use in
preparing your NGS analysis.

29
Sample & Assay Technologies

GeneRead Library Quantification System
NGS library quantification for any sequencing application

, Ion Proton

30
Sample & Assay Technologies

GeneRead DNAseq & LQ System: Summary

 Focused:
 Biologically relevant content selection enables deep sequencing on
relevant genes and identification of rare mutations
 Flexible:
 Mix and match any gene of interest
 NGS platform independent:
 Functionally validated for IT PGM, MiSeq/HiSeq
 Integrated controls:
 Enabling quality control of prepared library before sequencing
 Free, complete and easy of use data analysis tool
31
Sample & Assay Technologies

GeneRead DNAseq Panel & Library Quant System for NGS

Questions?
Contact Technical Support: 9 AM – 6 PM M – F ET
Contact: 1-800-742-4368 OR support@SABiosciences.com
Shankar Sellappan, Ph.D. (Global Product Manager)
Shankar.Sellappan@QIAGEN.com
Ph.D. Trained Application Scientists
 Available Before, During, and After Your Experiments for Consultation / Help
32

Mais conteúdo relacionado

Mais procurados

QIAseq Targeted DNA, RNA and Fusion Gene Panels
QIAseq Targeted DNA, RNA and Fusion Gene PanelsQIAseq Targeted DNA, RNA and Fusion Gene Panels
QIAseq Targeted DNA, RNA and Fusion Gene PanelsQIAGEN
 
Digital RNAseq for Gene Expression Profiling: Digital RNAseq Webinar Part 2
Digital RNAseq for Gene Expression Profiling: Digital RNAseq Webinar Part 2Digital RNAseq for Gene Expression Profiling: Digital RNAseq Webinar Part 2
Digital RNAseq for Gene Expression Profiling: Digital RNAseq Webinar Part 2QIAGEN
 
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...QIAGEN
 
Sensitive and Reliable Variant Detection From Challenging Samples
Sensitive and Reliable Variant Detection From Challenging SamplesSensitive and Reliable Variant Detection From Challenging Samples
Sensitive and Reliable Variant Detection From Challenging SamplesQIAGEN
 
Fast and Efficient Post-Bisulfite-Seq Library Construction with QIAseq Ultral...
Fast and Efficient Post-Bisulfite-Seq Library Construction with QIAseq Ultral...Fast and Efficient Post-Bisulfite-Seq Library Construction with QIAseq Ultral...
Fast and Efficient Post-Bisulfite-Seq Library Construction with QIAseq Ultral...QIAGEN
 
Accurate detection of low frequency genetic variants using novel, molecular t...
Accurate detection of low frequency genetic variants using novel, molecular t...Accurate detection of low frequency genetic variants using novel, molecular t...
Accurate detection of low frequency genetic variants using novel, molecular t...Integrated DNA Technologies
 
Analyzing Fusion Genes Using Next-Generation Sequencing
Analyzing Fusion Genes Using Next-Generation SequencingAnalyzing Fusion Genes Using Next-Generation Sequencing
Analyzing Fusion Genes Using Next-Generation SequencingQIAGEN
 
Aug2014 abrf interlaboratory study plans
Aug2014 abrf interlaboratory study plansAug2014 abrf interlaboratory study plans
Aug2014 abrf interlaboratory study plansGenomeInABottle
 
Analysis and Interpretation of Cell-free DNA
Analysis and Interpretation of Cell-free DNAAnalysis and Interpretation of Cell-free DNA
Analysis and Interpretation of Cell-free DNAQIAGEN
 
Apac distributor training series 3 swift product for cancer study
Apac distributor training series 3  swift product for cancer studyApac distributor training series 3  swift product for cancer study
Apac distributor training series 3 swift product for cancer studySwift Biosciences
 
Digital RNAseq Technology Introduction: Digital RNAseq Webinar Part 1
Digital RNAseq Technology Introduction: Digital RNAseq Webinar Part 1Digital RNAseq Technology Introduction: Digital RNAseq Webinar Part 1
Digital RNAseq Technology Introduction: Digital RNAseq Webinar Part 1QIAGEN
 
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...QIAGEN
 
Investigate the Molecular Basis of Disease
Investigate the Molecular Basis of DiseaseInvestigate the Molecular Basis of Disease
Investigate the Molecular Basis of DiseaseQIAGEN
 
Emergingroleo fmi rnainmedicalsciences
Emergingroleo fmi rnainmedicalsciencesEmergingroleo fmi rnainmedicalsciences
Emergingroleo fmi rnainmedicalscienceskarenbbs
 
Quality Control of RNA Samples — For Gene Expression Results You Can Rely On
Quality Control of RNA Samples — For Gene Expression Results You Can Rely OnQuality Control of RNA Samples — For Gene Expression Results You Can Rely On
Quality Control of RNA Samples — For Gene Expression Results You Can Rely OnQIAGEN
 
New Progress in Pyrosequencing for Automated Quantitative Analysis of Bi- or ...
New Progress in Pyrosequencing for Automated Quantitative Analysis of Bi- or ...New Progress in Pyrosequencing for Automated Quantitative Analysis of Bi- or ...
New Progress in Pyrosequencing for Automated Quantitative Analysis of Bi- or ...QIAGEN
 
The quest for high confidence mutations in plasma: searching for a needle in ...
The quest for high confidence mutations in plasma: searching for a needle in ...The quest for high confidence mutations in plasma: searching for a needle in ...
The quest for high confidence mutations in plasma: searching for a needle in ...Integrated DNA Technologies
 
The QIAseq NGS Portfolio for Cancer Research: Sample-to-Insight for All
The QIAseq NGS Portfolio for Cancer Research: Sample-to-Insight for AllThe QIAseq NGS Portfolio for Cancer Research: Sample-to-Insight for All
The QIAseq NGS Portfolio for Cancer Research: Sample-to-Insight for AllQIAGEN
 

Mais procurados (20)

QIAseq Targeted DNA, RNA and Fusion Gene Panels
QIAseq Targeted DNA, RNA and Fusion Gene PanelsQIAseq Targeted DNA, RNA and Fusion Gene Panels
QIAseq Targeted DNA, RNA and Fusion Gene Panels
 
Digital RNAseq for Gene Expression Profiling: Digital RNAseq Webinar Part 2
Digital RNAseq for Gene Expression Profiling: Digital RNAseq Webinar Part 2Digital RNAseq for Gene Expression Profiling: Digital RNAseq Webinar Part 2
Digital RNAseq for Gene Expression Profiling: Digital RNAseq Webinar Part 2
 
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
 
Sensitive and Reliable Variant Detection From Challenging Samples
Sensitive and Reliable Variant Detection From Challenging SamplesSensitive and Reliable Variant Detection From Challenging Samples
Sensitive and Reliable Variant Detection From Challenging Samples
 
DNA_Services
DNA_ServicesDNA_Services
DNA_Services
 
Fast and Efficient Post-Bisulfite-Seq Library Construction with QIAseq Ultral...
Fast and Efficient Post-Bisulfite-Seq Library Construction with QIAseq Ultral...Fast and Efficient Post-Bisulfite-Seq Library Construction with QIAseq Ultral...
Fast and Efficient Post-Bisulfite-Seq Library Construction with QIAseq Ultral...
 
Accurate detection of low frequency genetic variants using novel, molecular t...
Accurate detection of low frequency genetic variants using novel, molecular t...Accurate detection of low frequency genetic variants using novel, molecular t...
Accurate detection of low frequency genetic variants using novel, molecular t...
 
Analyzing Fusion Genes Using Next-Generation Sequencing
Analyzing Fusion Genes Using Next-Generation SequencingAnalyzing Fusion Genes Using Next-Generation Sequencing
Analyzing Fusion Genes Using Next-Generation Sequencing
 
Bio conference live 2013
Bio conference live 2013Bio conference live 2013
Bio conference live 2013
 
Aug2014 abrf interlaboratory study plans
Aug2014 abrf interlaboratory study plansAug2014 abrf interlaboratory study plans
Aug2014 abrf interlaboratory study plans
 
Analysis and Interpretation of Cell-free DNA
Analysis and Interpretation of Cell-free DNAAnalysis and Interpretation of Cell-free DNA
Analysis and Interpretation of Cell-free DNA
 
Apac distributor training series 3 swift product for cancer study
Apac distributor training series 3  swift product for cancer studyApac distributor training series 3  swift product for cancer study
Apac distributor training series 3 swift product for cancer study
 
Digital RNAseq Technology Introduction: Digital RNAseq Webinar Part 1
Digital RNAseq Technology Introduction: Digital RNAseq Webinar Part 1Digital RNAseq Technology Introduction: Digital RNAseq Webinar Part 1
Digital RNAseq Technology Introduction: Digital RNAseq Webinar Part 1
 
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
 
Investigate the Molecular Basis of Disease
Investigate the Molecular Basis of DiseaseInvestigate the Molecular Basis of Disease
Investigate the Molecular Basis of Disease
 
Emergingroleo fmi rnainmedicalsciences
Emergingroleo fmi rnainmedicalsciencesEmergingroleo fmi rnainmedicalsciences
Emergingroleo fmi rnainmedicalsciences
 
Quality Control of RNA Samples — For Gene Expression Results You Can Rely On
Quality Control of RNA Samples — For Gene Expression Results You Can Rely OnQuality Control of RNA Samples — For Gene Expression Results You Can Rely On
Quality Control of RNA Samples — For Gene Expression Results You Can Rely On
 
New Progress in Pyrosequencing for Automated Quantitative Analysis of Bi- or ...
New Progress in Pyrosequencing for Automated Quantitative Analysis of Bi- or ...New Progress in Pyrosequencing for Automated Quantitative Analysis of Bi- or ...
New Progress in Pyrosequencing for Automated Quantitative Analysis of Bi- or ...
 
The quest for high confidence mutations in plasma: searching for a needle in ...
The quest for high confidence mutations in plasma: searching for a needle in ...The quest for high confidence mutations in plasma: searching for a needle in ...
The quest for high confidence mutations in plasma: searching for a needle in ...
 
The QIAseq NGS Portfolio for Cancer Research: Sample-to-Insight for All
The QIAseq NGS Portfolio for Cancer Research: Sample-to-Insight for AllThe QIAseq NGS Portfolio for Cancer Research: Sample-to-Insight for All
The QIAseq NGS Portfolio for Cancer Research: Sample-to-Insight for All
 

Destaque

C1 clef pour_la_neuro
C1 clef pour_la_neuroC1 clef pour_la_neuro
C1 clef pour_la_neuroElsa von Licy
 
L agressivite en psychanalyse (21 pages 184 ko)
L agressivite en psychanalyse (21 pages   184 ko)L agressivite en psychanalyse (21 pages   184 ko)
L agressivite en psychanalyse (21 pages 184 ko)Elsa von Licy
 
Neuropsychophysiologie
NeuropsychophysiologieNeuropsychophysiologie
NeuropsychophysiologieElsa von Licy
 
Strategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfiStrategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfiElsa von Licy
 

Destaque (7)

C1 clef pour_la_neuro
C1 clef pour_la_neuroC1 clef pour_la_neuro
C1 clef pour_la_neuro
 
Ngs introduction
Ngs introductionNgs introduction
Ngs introduction
 
L agressivite en psychanalyse (21 pages 184 ko)
L agressivite en psychanalyse (21 pages   184 ko)L agressivite en psychanalyse (21 pages   184 ko)
L agressivite en psychanalyse (21 pages 184 ko)
 
Neuropsychophysiologie
NeuropsychophysiologieNeuropsychophysiologie
Neuropsychophysiologie
 
Hemostase polycop
Hemostase polycopHemostase polycop
Hemostase polycop
 
Rainville pierre
Rainville pierreRainville pierre
Rainville pierre
 
Strategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfiStrategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfi
 

Semelhante a 2012 10-24 - ngs webinar

Digital DNA-seq Technology: Targeted Enrichment for Cancer Research
Digital DNA-seq Technology: Targeted Enrichment for Cancer ResearchDigital DNA-seq Technology: Targeted Enrichment for Cancer Research
Digital DNA-seq Technology: Targeted Enrichment for Cancer ResearchQIAGEN
 
Exploring new frontiers with next-generation sequencing
Exploring new frontiers with next-generation sequencingExploring new frontiers with next-generation sequencing
Exploring new frontiers with next-generation sequencingQIAGEN
 
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...QIAGEN
 
Next generation sequencing & microarray-- Genotypic Technology
Next generation sequencing & microarray-- Genotypic TechnologyNext generation sequencing & microarray-- Genotypic Technology
Next generation sequencing & microarray-- Genotypic TechnologyGenotypic Technology
 
Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...
Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...
Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...QIAGEN
 
Oncogenomics july 2012
Oncogenomics july 2012Oncogenomics july 2012
Oncogenomics july 2012Elsa von Licy
 
Advanced Real-Time PCR Array Technology – Coding and Noncoding RNA Expression...
Advanced Real-Time PCR Array Technology – Coding and Noncoding RNA Expression...Advanced Real-Time PCR Array Technology – Coding and Noncoding RNA Expression...
Advanced Real-Time PCR Array Technology – Coding and Noncoding RNA Expression...QIAGEN
 
Sample to Insight: RNA Samples Infographic
Sample to Insight: RNA Samples InfographicSample to Insight: RNA Samples Infographic
Sample to Insight: RNA Samples InfographicQIAGEN
 
Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012
Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012
Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012sequencing_columbia
 
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...GenomeInABottle
 
Genome in a bottle for amp GeT-RM 181030
Genome in a bottle for amp GeT-RM 181030Genome in a bottle for amp GeT-RM 181030
Genome in a bottle for amp GeT-RM 181030GenomeInABottle
 
Polymerase Chain Reaction
Polymerase Chain ReactionPolymerase Chain Reaction
Polymerase Chain Reactionsara_abudahab
 
Genome in a bottle for ashg grc giab workshop 181016
Genome in a bottle for ashg grc giab workshop 181016Genome in a bottle for ashg grc giab workshop 181016
Genome in a bottle for ashg grc giab workshop 181016GenomeInABottle
 

Semelhante a 2012 10-24 - ngs webinar (20)

Digital DNA-seq Technology: Targeted Enrichment for Cancer Research
Digital DNA-seq Technology: Targeted Enrichment for Cancer ResearchDigital DNA-seq Technology: Targeted Enrichment for Cancer Research
Digital DNA-seq Technology: Targeted Enrichment for Cancer Research
 
Exploring new frontiers with next-generation sequencing
Exploring new frontiers with next-generation sequencingExploring new frontiers with next-generation sequencing
Exploring new frontiers with next-generation sequencing
 
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
 
Next generation sequencing & microarray-- Genotypic Technology
Next generation sequencing & microarray-- Genotypic TechnologyNext generation sequencing & microarray-- Genotypic Technology
Next generation sequencing & microarray-- Genotypic Technology
 
Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...
Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...
Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...
 
Oncogenomics july 2012
Oncogenomics july 2012Oncogenomics july 2012
Oncogenomics july 2012
 
Advanced Real-Time PCR Array Technology – Coding and Noncoding RNA Expression...
Advanced Real-Time PCR Array Technology – Coding and Noncoding RNA Expression...Advanced Real-Time PCR Array Technology – Coding and Noncoding RNA Expression...
Advanced Real-Time PCR Array Technology – Coding and Noncoding RNA Expression...
 
Oncogenomics 2013
Oncogenomics 2013Oncogenomics 2013
Oncogenomics 2013
 
Sample to Insight: RNA Samples Infographic
Sample to Insight: RNA Samples InfographicSample to Insight: RNA Samples Infographic
Sample to Insight: RNA Samples Infographic
 
Pcrarray
PcrarrayPcrarray
Pcrarray
 
Pcr array 2013
Pcr array 2013Pcr array 2013
Pcr array 2013
 
Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012
Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012
Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012
 
Ngs part ii 2013
Ngs part ii 2013Ngs part ii 2013
Ngs part ii 2013
 
Cn presentation
Cn presentationCn presentation
Cn presentation
 
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
 
Genome in a bottle for amp GeT-RM 181030
Genome in a bottle for amp GeT-RM 181030Genome in a bottle for amp GeT-RM 181030
Genome in a bottle for amp GeT-RM 181030
 
Polymerase Chain Reaction
Polymerase Chain ReactionPolymerase Chain Reaction
Polymerase Chain Reaction
 
Genome in a bottle for ashg grc giab workshop 181016
Genome in a bottle for ashg grc giab workshop 181016Genome in a bottle for ashg grc giab workshop 181016
Genome in a bottle for ashg grc giab workshop 181016
 
RMR-Nirma-NGS-Heena.pdf
RMR-Nirma-NGS-Heena.pdfRMR-Nirma-NGS-Heena.pdf
RMR-Nirma-NGS-Heena.pdf
 
Ngs part i 2013
Ngs part i 2013Ngs part i 2013
Ngs part i 2013
 

Mais de Elsa von Licy

Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...Elsa von Licy
 
Vuillez jean philippe_p01
Vuillez jean philippe_p01Vuillez jean philippe_p01
Vuillez jean philippe_p01Elsa von Licy
 
Spr ue3.1 poly cours et exercices
Spr ue3.1   poly cours et exercicesSpr ue3.1   poly cours et exercices
Spr ue3.1 poly cours et exercicesElsa von Licy
 
Plan de cours all l1 l2l3m1m2 p
Plan de cours all l1 l2l3m1m2 pPlan de cours all l1 l2l3m1m2 p
Plan de cours all l1 l2l3m1m2 pElsa von Licy
 
Bioph pharm 1an-viscosit-des_liquides_et_des_solutions
Bioph pharm 1an-viscosit-des_liquides_et_des_solutionsBioph pharm 1an-viscosit-des_liquides_et_des_solutions
Bioph pharm 1an-viscosit-des_liquides_et_des_solutionsElsa von Licy
 
Poly histologie-et-embryologie-medicales
Poly histologie-et-embryologie-medicalesPoly histologie-et-embryologie-medicales
Poly histologie-et-embryologie-medicalesElsa von Licy
 
Methodes travail etudiants
Methodes travail etudiantsMethodes travail etudiants
Methodes travail etudiantsElsa von Licy
 
Atelier.etude.efficace
Atelier.etude.efficaceAtelier.etude.efficace
Atelier.etude.efficaceElsa von Licy
 
There is no_such_thing_as_a_social_science_intro
There is no_such_thing_as_a_social_science_introThere is no_such_thing_as_a_social_science_intro
There is no_such_thing_as_a_social_science_introElsa von Licy
 
Principles and neurobiological_correlates_of.5
Principles and neurobiological_correlates_of.5Principles and neurobiological_correlates_of.5
Principles and neurobiological_correlates_of.5Elsa von Licy
 
A short history of man — progress and decline
A short history of man — progress and declineA short history of man — progress and decline
A short history of man — progress and declineElsa von Licy
 
Commento a 'meditazione sui tarocchi'
Commento a 'meditazione sui tarocchi'Commento a 'meditazione sui tarocchi'
Commento a 'meditazione sui tarocchi'Elsa von Licy
 

Mais de Elsa von Licy (20)

Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
 
Antiphilos
AntiphilosAntiphilos
Antiphilos
 
Vuillez jean philippe_p01
Vuillez jean philippe_p01Vuillez jean philippe_p01
Vuillez jean philippe_p01
 
Spr ue3.1 poly cours et exercices
Spr ue3.1   poly cours et exercicesSpr ue3.1   poly cours et exercices
Spr ue3.1 poly cours et exercices
 
Plan de cours all l1 l2l3m1m2 p
Plan de cours all l1 l2l3m1m2 pPlan de cours all l1 l2l3m1m2 p
Plan de cours all l1 l2l3m1m2 p
 
M2 bmc2007 cours01
M2 bmc2007 cours01M2 bmc2007 cours01
M2 bmc2007 cours01
 
Feuilletage
FeuilletageFeuilletage
Feuilletage
 
Chapitre 1
Chapitre 1Chapitre 1
Chapitre 1
 
Biophy
BiophyBiophy
Biophy
 
Bioph pharm 1an-viscosit-des_liquides_et_des_solutions
Bioph pharm 1an-viscosit-des_liquides_et_des_solutionsBioph pharm 1an-viscosit-des_liquides_et_des_solutions
Bioph pharm 1an-viscosit-des_liquides_et_des_solutions
 
Poly histologie-et-embryologie-medicales
Poly histologie-et-embryologie-medicalesPoly histologie-et-embryologie-medicales
Poly histologie-et-embryologie-medicales
 
Methodes travail etudiants
Methodes travail etudiantsMethodes travail etudiants
Methodes travail etudiants
 
Atelier.etude.efficace
Atelier.etude.efficaceAtelier.etude.efficace
Atelier.etude.efficace
 
There is no_such_thing_as_a_social_science_intro
There is no_such_thing_as_a_social_science_introThere is no_such_thing_as_a_social_science_intro
There is no_such_thing_as_a_social_science_intro
 
Prolegomena 4 0
Prolegomena 4 0Prolegomena 4 0
Prolegomena 4 0
 
Swa 2015 final
Swa 2015 finalSwa 2015 final
Swa 2015 final
 
Principles and neurobiological_correlates_of.5
Principles and neurobiological_correlates_of.5Principles and neurobiological_correlates_of.5
Principles and neurobiological_correlates_of.5
 
A short history of man — progress and decline
A short history of man — progress and declineA short history of man — progress and decline
A short history of man — progress and decline
 
Commento a 'meditazione sui tarocchi'
Commento a 'meditazione sui tarocchi'Commento a 'meditazione sui tarocchi'
Commento a 'meditazione sui tarocchi'
 
Valentin tomberg
Valentin tombergValentin tomberg
Valentin tomberg
 

2012 10-24 - ngs webinar

  • 1. Sample & Assay Technologies GeneRead DNAseq Targeted Exon Enrichment & GeneRead Library Quantification System for Next Generation Sequencing Shankar Sellappan, Ph.D. Global Product Manager Shankar.Sellappan@QIAGEN.com 1
  • 2. Sample & Assay Technologies Pathway-Focused Analysis Tools 2
  • 3. Sample & Assay Technologies GeneRead DNAseq & Library Quant NGS System Agenda  Introduction  Targeted Enrichment  Workflow  Principles  Data Analysis  Pathway Content  Performance Data  Application Example  Library Quantification  Workflow  Application Example  Summary 3
  • 4. Sample & Assay Technologies Individual participants Cell cycle P53 MDM2 Cyclins CDKs Biological Markers Define Biological Processes Angiogenesis VEGF bFGF ANGPT PDGF Inflammation IL8 TLR IFNγ TNFβ 4
  • 5. Sample & Assay Technologies Complete Biological Story Built on Pathway / Network Analysis Angiogenesis Inflammation Pathway Cell cycle 5
  • 6. Sample & Assay Technologies Patient sample = Wild-type = Determining DNA Differences ATGCCATCTGGGACGGGTCAGTAG ATGCCATCTGTGACGGGTCAGTAG How could that SINGLE base difference make the person sick? Let’s look at the amino acids that are translated in both samples: Patient sample DNA = Amino Acid Sequence = ATG CCA TCT GGG ACG GGT CAG TAG Met P S G T G Q Stop Valine Glycine Compare the two amino acid sequences: Patient sample AA Sequence = Wild-Type AA Sequence = Met P S G T G Q Stop Met P S V T G Q Stop If the wild-type protein, with the Valine positioned here, looked like: and in the patient sample, it is a Glycine, and it looks like: Well….the protein just won’t work. 6
  • 7. Sample & Assay Technologies What is NGS (Next Generation Sequencing)? Massively Paralleled Sequencing Instead of sequencing a DNA sequence from Sequence many small pieces at the same time 7
  • 8. Sample & Assay Technologies When doing NGS analysis, what are you looking for? Easy-to-use workflow and Data output Detection of Low Prevalence Somatic Mutation in FFPE Lung Adenocarcinoma Sample Human Lung Cancer GeneRead DNASeq Gene panel was used to enrich 20 genes in genomic DNA isolated from three FFPE lung adenocarcinoma and one FFPE normal lung samples. Sequencing data was analyzed using QIAGEN NGS Data Analysis Web Portal and high quality variants were filtered. 8
  • 9. Sample & Assay Technologies Your NGS research needs  Identify low frequency DNA mutation variants  Work with low quality DNA samples, such as FFPE samples  Focus efforts on a focused set of genes important to their research  Simple methodology to make variant calls  Selective sequencing saves sequencing capacity 9
  • 10. Sample & Assay Technologies Traditional NGS Workflow Isolate DNA Library Prep & Quantification NGS Sequence Analysis & Variant ID • Whole genome analysis • Too much irrelevant data • Poor quality reads / coverage 10
  • 11. Sample & Assay Technologies New NGS Workflow with Targeted Enrichment 80 ng Achieve more sensitive mutation detection with 1 additional step • Focused on your genes of interest • Why look at all 20,000 genes in the human genome when you are interested in only a few? • Enables deep sequencing to ID low frequency mutation / rare variants • Integrated controls to assess target enrichment 11
  • 12. Sample & Assay Technologies Target Enrichment: Principles Multiplex PCR-enabled enrichment of gene of interest We provide primer sets that produce overlapping PCR products • For any gene or set of genes in the human genome Division of non-adjacent gene primer sets into 4 tubes increases amplification specificity. 12
  • 13. Sample & Assay Technologies Targeted Enrichment: Details ~ 150 bp PCR products 13
  • 14. Sample & Assay Technologies Complete Analysis Workflow With integrated controls to assess sample quality / TE process 14
  • 15. Sample & Assay Technologies NGS Sequence Analysis and Variant ID Software  FREE Complete & Easy to use Data Analysis with Web-based Software 15
  • 16. Sample & Assay Technologies Read Mode: Paired End vs Single End Goal: Increased # of Reads / Amplicon Sequence of Interest: TACGCATCGATGCGGTAACTGCTGATCGTCGTAGTGCTAGCTGA Single End Sequencing: TACGCATCGATGCGGTAACTGCTGATCGTCGTAGTGCTAGCTGA Paired End Sequencing (both ends are sequenced): TACGCATCGATGCGGTAACTGCTGATCGTCGTAGTGCTAGCTGA AGTCGATCGTGATGCTGCTAGTCGTCAATGGCGTAGCTACGCAT
  • 17. Sample & Assay Technologies How Genes on Panels Are Selected  Comprehensive Cancer Panel (124 genes)  Disease Focused Gene Panels (20 genes)  Breast cancer Liver cancer  Colon Cancer Lung Cancer  Gastric cancer Ovarian Cancer  Leukemia Prostate Cancer  Genes with High Relevance  Biologically relevant gene content  Clinically relevant: Published association with the disease state – Multiple Publically accessible databases – Text mining tools – Manually curated  Genes Involved in Disease ALSO AVAILABLE: Custom Panels from ANY GENE or COLLECTION OF GENES in Human Genome Technically relevant gene content  Most frequently mutated genes  Specific feedback from the thought leaders 17
  • 18. Sample & Assay Technologies Targeted Enrichment: Panel Information
  • 19. Sample & Assay Technologies Targeted Enrichment: Panel Information
  • 20. Sample & Assay Technologies NGS Target Enrichment Design Strategy Commonly encountered issues solved by GeneRead Algorithm • Design Coverage • How much of the gene is covered by your amplicons • Sequence Coverage Uniformity • How much ease base pair is covered: Ideally, it should be uniform • Specificity • % of reads mapped back to your sequence of interest 20
  • 21. Sample & Assay Technologies GeneRead DNAseq Gene Panel: Performance data % Covered by Design Design coverage GeneRead DNAseq Custom Panel GeneRead DNAseq Lung Cancer Panel GeneRead DNAseq Comprehensive Cancer Panel Discover more potential variants by covering more exons for genes of interest in assay design 21
  • 22. Sample & Assay Technologies GeneRead DNAseq Gene Panel: Performance data Sequence coverage uniformity GeneRead DNAseq Custom Panel GeneRead DNAseq Lung Cancer Panel GeneRead DNAseq Comprehensive Cancer Panel More bases sequenced above minimum read depth, generating more high-quality consensus calls. 22
  • 23. Sample & Assay Technologies GeneRead DNAseq Gene Panel: Performance data Specificity (% on-target reads) Specificity (On-target reads)* GeneRead DNAseq Custom Panel GeneRead DNAseq Lung Cancer Panel GeneRead DNAseq Comprehensive Cancer Panel No wasting of sequencing capacity * On-Target Reads= Number of reads on target out of total number of reads per run 23
  • 24. Sample & Assay Technologies DNAseq Gene Panel Application Data KRAS:G12V is present in all three FFPE lung adenocarcinomas Detection of Low Prevalence Somatic Mutation in FFPE Lung Adenocarcinoma Sample Human Lung Cancer GeneRead DNASeq Gene panel was used to enrich 20 genes in genomic DNA isolated from three FFPE lung adenocarcinoma and one FFPE normal lung samples. Sequencing data was analyzed using QIAGEN NGS Data Analysis Web Portal and high quality variants were filtered. NOTE: KRAS mutations confirmed by either Pyro or ARMS mutation assays (qBiomarker Somatic Mutation PCR Array) 24
  • 25. Sample & Assay Technologies Next-generation sequencing workflow Where does Library Quantification fit within the NGS workflow? Purification and amplification Sample enrichment Library preparation Next generation sequencing run Result verification (Optional) GeneRead (DNAseq) Library Quantification and QC System Why do you want to: 1. quantify their NGS DNA libraries 2. know the quality of their NGS DNA libraries?  You have to, in order to ensure high quality reads  Sequencing runs are expensive and time consuming, therefore, you want to ensure that downstream sequencing analyses are performed on samples of adequate quality for NGS technology. 25
  • 26. Sample & Assay Technologies Your needs Potential problems in NGS if library not quantified NGS methodology needs  Too much DNA  Mixed signals and un-resolvable data  Too little DNA  Reduced sequencing coverage  Reduced read depth  Empty runs  Increase cost per run  Wasted time Your needs  Simple and easy to perform method, with convenient and highthroughput format  Fast  Reliable and accurate quantification of sequencing targets  Unmet need: Assess quality of target enriched DNA  Efficient use of NGS capacity Potential methods for library QC  qPCR  Bioanalyzer  Qubit 26
  • 27. Sample & Assay Technologies Why choose qPCR for NGS Library Quantification? 1. BioAnalyzer measures total nucleic acids - Why is this a problem? 2. Low limit of detection 3. Consistency of results - For each technology, the greater the concentration of each sample (X-axis), the greater the # of clusters - This should be a linear relationship - Only qPCR provides this 27
  • 28. Sample & Assay Technologies NGS Library Quantification Made Easy Adapters can be quantified with qRT-PCR Step 1: You have your DNA (whole genome or target enriched) Step 2: You prepare the DNA library for NGS by adding (via ligation) NGS platformspecific adapters  NOTE: The adapters are short pieces of DNA Step 3: We provide you 2 reagents: 1. Pre-aliquoted dilutions of the standard 2. qPCR Primer Assays that detect the adapters Step 4: You perform qPCR with your sample. It should fall between our standard curve created with 5 sequential 10-fold dilutions. THAT is your library concentration to use in preparing your NGS analysis. 28
  • 29. Sample & Assay Technologies NGS Library Quantification Made Easy Adapters can be quantified with qRT-PCR Step 1: You have your DNA (whole genome or target enriched) Step 2: You prepare the DNA library for NGS by adding (via ligation) NGS platformspecific adapters  NOTE: The adapters are short pieces of DNA Step 3: We provide you 2 reagents: 1. Pre-aliquoted dilutions of the standard 2. qPCR Primer Assays that detect the adapters Step 4: You perform qPCR with your sample. It should fall between our standard curve created with 5 sequential 10-fold dilutions. THAT is your library concentration to use in preparing your NGS analysis. 29
  • 30. Sample & Assay Technologies GeneRead Library Quantification System NGS library quantification for any sequencing application , Ion Proton 30
  • 31. Sample & Assay Technologies GeneRead DNAseq & LQ System: Summary  Focused:  Biologically relevant content selection enables deep sequencing on relevant genes and identification of rare mutations  Flexible:  Mix and match any gene of interest  NGS platform independent:  Functionally validated for IT PGM, MiSeq/HiSeq  Integrated controls:  Enabling quality control of prepared library before sequencing  Free, complete and easy of use data analysis tool 31
  • 32. Sample & Assay Technologies GeneRead DNAseq Panel & Library Quant System for NGS Questions? Contact Technical Support: 9 AM – 6 PM M – F ET Contact: 1-800-742-4368 OR support@SABiosciences.com Shankar Sellappan, Ph.D. (Global Product Manager) Shankar.Sellappan@QIAGEN.com Ph.D. Trained Application Scientists  Available Before, During, and After Your Experiments for Consultation / Help 32